Selected article for: "anticancer treatment and follow phase"
Author: Hong-Yan Zhang; Lin-Wei Wang; Yuan-Yuan Chen; Xiao-Kun Shen; Qun Wang; You-Qin Yan; Yi Yu; Qiuji Wu; Xinghuan Wang; Ya-Hua Zhong; Melvin Chua Lee Kiang; Cong-Hua Xie
Title: A Multicentre Study of 2019 Novel Coronavirus Disease Outcomes of Cancer Patients in Wuhan, China
  • Document date: 2020_3_26
    • ID: 8rxjju0t_50
    Snippet: In this study, we reported the clinical characteristics and outcomes of COVID-19 in cancer patients. Both patients within the follow-up phase and ongoing anticancer treatment phase were at the risk of COVID-19. This study showed COVID-19 patients with cancer seem to have a higher proportion of severe cases and poorer prognosis. The tendency of poor prognosis was more obvious in patients at anticancer treatment phase. We should pay more intensive .....
    Document: In this study, we reported the clinical characteristics and outcomes of COVID-19 in cancer patients. Both patients within the follow-up phase and ongoing anticancer treatment phase were at the risk of COVID-19. This study showed COVID-19 patients with cancer seem to have a higher proportion of severe cases and poorer prognosis. The tendency of poor prognosis was more obvious in patients at anticancer treatment phase. We should pay more intensive attention to cancer patients, especially those with common risk factors of COVID-19.

    Search related documents:
    Co phrase search for related documents
    • anticancer treatment phase and poor prognosis: 1, 2
    • anticancer treatment phase and poor prognosis tendency: 1
    • anticancer treatment phase and treatment phase: 1, 2, 3, 4, 5
    • cancer patient and clinical characteristic: 1
    • cancer patient and follow phase: 1
    • cancer patient and intensive attention: 1, 2
    • cancer patient and poor prognosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • cancer patient and risk factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • cancer patient and severe case: 1, 2, 3, 4
    • cancer patient and study show: 1, 2
    • cancer patient and treatment phase: 1, 2, 3, 4
    • clinical characteristic and follow phase: 1
    • clinical characteristic and high proportion: 1
    • clinical characteristic and outcome clinical characteristic: 1, 2, 3, 4, 5, 6
    • clinical characteristic and risk factor: 1, 2, 3, 4, 5, 6, 7
    • clinical characteristic and severe case: 1, 2, 3, 4
    • clinical characteristic and study show: 1
    • common risk factor and high proportion: 1
    • common risk factor and risk factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72